Hampshire sues Purdue Pharma over opioid marketing
Send a link to a friend
[August 09, 2017] By
(Reuters) - New Hampshire sued OxyContin
maker Purdue Pharma LP on Tuesday, joining several state and local
governments in accusing the drugmaker of engaging in deceptive marketing
practices that have helped fuel a national opioid addiction epidemic.
The lawsuit filed in Merrimack County Superior Court claimed that
Purdue Pharma significantly downplayed the risk of addiction posed
by OxyContin and engaged in marketing practices that "opened the
floodgates" to opioid use and abuse.
The lawsuit came after the state's top court in June overturned a
ruling that barred the enforcement of subpoenas against Purdue and
four other drugmakers because of the use of a private law firm by
the office of the attorney general.
The complaint said the Stamford, Connecticut-based company had spent
hundreds of millions of dollars since the 1990s on misleading
marketing that overstated the benefits of opioids for treating
chronic, rather than short-term, pain.
Purdue and three executives in 2007 pleaded guilty to federal
charges related to the misbranding of OxyContin, and agreed to pay a
total of $634.5 million to resolve a U.S. Justice Department probe.
That year, the privately held company reached a $19.5 million
settlement with 26 states and the District of Columbia. It agreed in
2015 to pay $24 million to resolve a lawsuit by Kentucky.
The lawsuit by New Hampshire, which was not among those settled,
said Purdue has continued to benefit from its earlier misconduct and
has since 2011 expanded the market for opioids in the state.
"New Hampshire continues to experience a severe opioid epidemic,"
Deputy Attorney General Ann Rice said in a statement. "Last year
alone nearly 500 overdose deaths occurred - almost ten times more
than in 2000."
[to top of second column]
In a statement, Purdue denied the allegations but said "we share New
Hampshire officials' concerns about the opioid crisis and we are
committed to working collaboratively to find solutions."
According to the U.S. Centers for Disease Control and Prevention,
opioids were involved in over 33,000 U.S. deaths in 2015, the latest
year for which data is available, and estimates show the death rate
has continued rising.
The lawsuit followed similar cases against Purdue and other
drugmakers by Oklahoma, Mississippi, Ohio and Missouri and several
cities and counties in California, Illinois, Ohio, Oregon, Tennessee
and New York.
A group of state attorneys general announced an investigation in
June into the role played by pharmaceutical manufacturers in the
(Reporting by Nate Raymond in Boston; Editing by Chris Reese and
[© 2017 Thomson Reuters. All rights
Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.